Related Experiment Video
Updated: Jul 24, 2025

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
Ching Chen1,2, Liang-Yu Lin2,3, Jaw-Wen Chen1,2,4,5,6,7
1Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Background:
Higher chemokine C-X-C motif ligand 5 (CXCL5) level was observed in type 2 diabetes mellitus (DM) patients; however, its role in diabetic vasculopathy was not clarified. This study aimed to explore the impacts and mechanistic insights of CXCL5 in neovasculogenesis and wound healing in DM.
Methods:
Endothelial progenitor cells (EPCs) and human aortic endothelial cells (HAECs) were used in vitro. Streptozotocin-induced diabetic mice and Leprdb/JNarl mice were used as type 1 and type 2 DM models. Moreover, CXCL5 knockout mice were used to generate diabetic mice. Hindlimb ischemia surgery, aortic ring assays, matrigel plug assay, and wound healing assay were conducted.
Results:
CXCL5 concentrations were increased in plasma and EPCs culture medium from type 2 DM patients. CXCL5 neutralizing antibody upregulated vascular endothelial growth factor (VEGF)/stromal cell-derived factor-1 (SDF-1) and promoted cell function in EPCs from type 2 DM patients and high glucose-treated EPCs from non-DM subjects as well as HAECs. CXCL5 directly up-regulated interleukin (IL)-1β/IL-6/tumor necrosis factor-α and down-regulated VEGF/SDF-1 via ERK/p65 activation through chemokine C-X-C motif receptor 2 (CXCR2). CXCL5 neutralizing antibody recovered the blood flow after hindlimb ischemia, increased circulating EPC number, and enhanced VEGF and SDF-1 expression in ischemic muscle. CXCL5 suppression promoted neovascularization and wound healing in different diabetic animal models. The above observation could also be seen in streptozotocin-induced CXCL5 knockout diabetic mice.
Conclusions:
CXCL5 suppression could improve neovascularization and wound healing through CXCR2 in DM. CXCL5 may be regarded as a potential therapeutic target for vascular complications of DM.
Insights
Higher chemokine C-X-C motif ligand 5 (CXCL5) levels are linked to type 2 diabetes. Suppressing CXCL5 improves blood vessel formation and wound healing in diabetic models by targeting CXCR2.
Area of Science:
- Endocrinology and Metabolism
- Vascular Biology
- Immunology
Background:
- Elevated chemokine C-X-C motif ligand 5 (CXCL5) levels are observed in type 2 diabetes mellitus (DM) patients.
- The specific role of CXCL5 in diabetic vasculopathy, particularly in neovascularization and wound healing, remains unclear.
Purpose of the Study:
- To investigate the impact of CXCL5 on neovascularization and wound healing in diabetes mellitus.
- To elucidate the underlying mechanisms by which CXCL5 influences these processes in diabetic conditions.
Main Methods:
- In vitro studies utilized endothelial progenitor cells (EPCs) and human aortic endothelial cells (HAECs).
- In vivo studies employed streptozotocin-induced diabetic mice, Leprdb/JNarl mice, and CXCL5 knockout diabetic mice.
- Functional assessments included hindlimb ischemia, aortic ring assays, matrigel plug assays, and wound healing assays.
Main Results:
- CXCL5 levels were increased in plasma and EPCs from type 2 DM patients.
- CXCL5 neutralization upregulated VEGF/SDF-1, enhancing cell function and promoting neovascularization and wound healing in diabetic models.
- CXCL5 promoted inflammation (IL-1β, IL-6, TNF-α) and suppressed VEGF/SDF-1 via ERK/p65 activation through CXCR2.
Conclusions:
- Suppression of CXCL5 enhances neovascularization and wound healing in diabetes by acting through the CXCR2 pathway.
- CXCL5 represents a potential therapeutic target for managing vascular complications associated with diabetes mellitus.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
10:49Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Mechanism of Angiogenesis